134 related articles for article (PubMed ID: 31356754)
21. MicroRNA-204-5p modulates mitochondrial biogenesis in C2C12 myotubes and associates with oxidative capacity in humans.
Houzelle A; Dahlmans D; Nascimento EBM; Schaart G; Jörgensen JA; Moonen-Kornips E; Kersten S; Wang X; Hoeks J
J Cell Physiol; 2020 Dec; 235(12):9851-9863. PubMed ID: 32452584
[TBL] [Abstract][Full Text] [Related]
22. Effect of electrical stimulation-induced resistance exercise on mitochondrial fission and fusion proteins in rat skeletal muscle.
Kitaoka Y; Ogasawara R; Tamura Y; Fujita S; Hatta H
Appl Physiol Nutr Metab; 2015 Nov; 40(11):1137-42. PubMed ID: 26513006
[TBL] [Abstract][Full Text] [Related]
23. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.
Zorzano A; Hernández-Alvarez MI; Palacín M; Mingrone G
Biochim Biophys Acta; 2010; 1797(6-7):1028-33. PubMed ID: 20175989
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.
McAinch AJ; Cameron-Smith D
Diabetes Obes Metab; 2009 Jul; 11(7):721-8. PubMed ID: 19527483
[TBL] [Abstract][Full Text] [Related]
25. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
[TBL] [Abstract][Full Text] [Related]
26. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
Sparks LM; Bosma M; Brouwers B; van de Weijer T; Bilet L; Schaart G; Moonen-Kornips E; Eichmann TO; Lass A; Hesselink MKC; Schrauwen P
Diabetes; 2014 May; 63(5):1583-1593. PubMed ID: 24487026
[TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans.
Boyle KE; Zheng D; Anderson EJ; Neufer PD; Houmard JA
Int J Obes (Lond); 2012 Aug; 36(8):1025-31. PubMed ID: 22024640
[TBL] [Abstract][Full Text] [Related]
29. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes.
Zorzano A; Liesa M; Palacín M
Int J Biochem Cell Biol; 2009 Oct; 41(10):1846-54. PubMed ID: 19703653
[TBL] [Abstract][Full Text] [Related]
30. Increased susceptibility to oxidative damage in post-diabetic human myotubes.
Costford SR; Crawford SA; Dent R; McPherson R; Harper ME
Diabetologia; 2009 Nov; 52(11):2405-15. PubMed ID: 19685293
[TBL] [Abstract][Full Text] [Related]
31. Role of Parkin and endurance training on mitochondrial turnover in skeletal muscle.
Chen CCW; Erlich AT; Hood DA
Skelet Muscle; 2018 Mar; 8(1):10. PubMed ID: 29549884
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes.
Gaster M
Biochem Biophys Res Commun; 2011 Jan; 404(4):1023-8. PubMed ID: 21187069
[TBL] [Abstract][Full Text] [Related]
33. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
Abu Bakar MH; Sarmidi MR
Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
[TBL] [Abstract][Full Text] [Related]
34. Conditioned media from contracting skeletal muscle potentiates insulin secretion and enhances mitochondrial energy metabolism of pancreatic beta-cells.
Barlow J; Solomon TPJ
Metabolism; 2019 Feb; 91():1-9. PubMed ID: 30445139
[TBL] [Abstract][Full Text] [Related]
35. Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids.
Corpeleijn E; Hessvik NP; Bakke SS; Levin K; Blaak EE; Thoresen GH; Gaster M; Rustan AC
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E14-22. PubMed ID: 20442319
[TBL] [Abstract][Full Text] [Related]
36. The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control.
Minet AD; Gaster M
Biochem Biophys Res Commun; 2011 Jun; 409(4):591-5. PubMed ID: 21513703
[TBL] [Abstract][Full Text] [Related]
37. ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects.
Minet AD; Gaster M
Biochem Biophys Res Commun; 2010 Nov; 402(1):70-4. PubMed ID: 20920472
[TBL] [Abstract][Full Text] [Related]
38. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
39. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics.
Chen MB; McAinch AJ; Macaulay SL; Castelli LA; O'brien PE; Dixon JB; Cameron-Smith D; Kemp BE; Steinberg GR
J Clin Endocrinol Metab; 2005 Jun; 90(6):3665-72. PubMed ID: 15769985
[TBL] [Abstract][Full Text] [Related]
40. Increased proton leak and SOD2 expression in myotubes from obese non-diabetic subjects with a family history of type 2 diabetes.
Aguer C; Pasqua M; Thrush AB; Moffat C; McBurney M; Jardine K; Zhang R; Beauchamp B; Dent R; McPherson R; Harper ME
Biochim Biophys Acta; 2013 Oct; 1832(10):1624-33. PubMed ID: 23685312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
